Neurodegenerative diseases such as Alzheimer's or Parkinson's are associated with the prionlike propagation and aggregation of toxic proteins. A long standing hypothesis that amyloid-beta drives Alzheimer's disease has proven the subject of contemporary controversy; leading to new research in both the role of tau protein and its interaction with amyloid-beta. Conversely, recent work in mathematical modelling has demonstrated the relevance of nonlinear reaction-diffusion type equations to capture essential features of the disease. Such approaches have been further simplified, to network-based models, and offer researchers a powerful set of computationally tractable tools with which to investigate neurodegenerative disease dynamics.
Introduction
Neurodegenerative diseases such as Alzheimer's (AD) or Parkinson's (AD) are associated with the propagation and aggregation of toxic proteins. In the case of AD, it was Alzheimer himself who showed the importance of both amyloid-β (Aβ) plaques and tau-protein (τ P) neurofibrillary tangles (NFT) in what he called the "disease of forgetfulness" [1, 2] . These two proteins are very different. Aβ forms extracellular aggregates and plaques whereas τ P are intracellular proteins involved in the stabilization of axons by cross-linking microtubules that can form large disorganized tangles [3, 4] . Since the early 90's, when it was first formulated, the "amyloid cascade hypothesis" has by direct simulation. Typical approaches for organ-size simulation of dementia progression [35] take the form of either continuous models formulated in terms of anisotropic reaction-diffusion equations [36, 37, 38] , or discrete systems on the brain's connectome network. The discrete approach can be further divided into pure-diffusion linear models [39, 40, 41, 42, 43] , probabilistic models [44, 45, 46] , or deterministic models [47, 48] . We start with a continuous deterministic model consisting of two coupled heterodimer subsystems and augmented with a coarse-grained damage model. Our general approach, following [48] is to study some of the key properties of this continuous model before discretizing it on a network and solving it numerically on the brain's connectome graph.
Model

Continuous model
Following the heterodimer model, first introduced in the context of prion propagation [49, 50] , we consider two populations of proteins in either healthy or toxic form. We have a spatial domain Ω ⊂ R 3 and, for x ∈ Ω and time t ∈ R + , we denote by u = u(x, t), and v = v(x, t) the concentration of healthy Aβ and τ P. Similarly, we denote byũ =ũ(x, t), andṽ =ṽ(x, t), the concentration of toxic Aβ and τ P, respectively. Then, the concentration evolution is governed by 
Here, the parameters are as follows: (a 0 , b 0 ) is the production of healthy proteins, (a 1 , b 1 ,ã 1 ,b 1 ) is the clearance of healthy and toxic proteins, and (a 2 , b 2 ) reflect the conversion of healthy proteins to toxic proteins. The coupling between the two, otherwise separate, heterodimer models for Aβ and τ P is realized via b 3 . The b 3 predicated terms arise from the mode of interaction assumption, c.f. M1 above, dictating that the presence of Aβ augments the conversion process of healthy τ P to toxic τ P. We note that toxic Aβ acts as an enzyme in this process and is therefore not depleted. In the absence of production and clearance maps, we assume that all these parameters are constant in space and time. The symmetric diffusion tensors D 1,2 andD 1,2 characterize the spreading of each proteins. For isotropic diffusion, these tensors are a multiple of the identity, D 1,2 = d 1,2 1 and ∇ · (D 1,2 · ∇(•)) = d 1,2 ∆(•) is the usual Laplacian operator (and similarly for the toxic part). For anisotropic diffusion, the eigenvector with the largest eigenvalue describes the direction of faster diffusion which is used to model preferential propagation along axonal pathways [37] . For the evolution of the damage, we define a damage variable q = q(x, t) ∈ [0, 1] and assume a first-order rate model:q = (k 1ũ + k 2ṽ + k 3ũṽ + k 4 A(q)) (1 − q), q(x, 0) = 0,
where the first two parameters denote the toxicity due to the isolated presence of either toxic protein and the third term accounts for their combined effect. Thus, the third term engenders both toxic effects M2 and M3. The term A(q) represents the effect of transneuronal degeneration whereby the damage of neighbouring neurons increases the probability of damage [51] . This term does not have a simple representation within the continuous framework as the positions of neuronal bodies is not explicitly encoded. However, we will see that in the discrete case, there is a natural way to take this effect into account and we will delay the examination of this term to the network model. As far as the continuous model is considered we will take, in the first instance, k 4 = 0.
Network model
A simple coarse-grain model of the continuous system can be obtained by building a network from brain data. The construction is obtained by defining nodes of the network to be regions of interest in the domain Ω, typically associated with well-known areas from a brain atlas. The edges of this network are defined as the connections regions of interest and use the connections between regions as edges on this network. The brain connectome is then modeled as a weighted graph G with V nodes and E edges obtained from diffusion tensor imaging and tractography. Its weighted adjacency matrix W is obtained as the ratio of mean fiber number n ij by length squared, l 2 ij , between node i and node j.
W ij = n ij l 2 ij , i, j = 1, . . . , V.
The weighted degree matrix is the diagonal matrix with elements
W ij , i, j = 1, . . . , V.
Additionally, we define the graph Laplacian L as
where ρ is an overall effective diffusion constant. The adjacency matrix for the simulation is derived from the tractography of diffusion tensor magnetic resonance images corresponding to 418 healthy subjects of the Human Connectome Project [52] given by Budapest Reference Connectome v3.0 [53] . The graph contains V =1015 nodes and E =70,892 edges and is shown in Figure 1 . Let (u j ,ũ j ) be the concentration of healthy and toxic Aβ and (v j ,ṽ j ) denote the concentration of healthy and toxic τ P at node j. The network equations corresponding to the continuous model then take the form of a system of first-order ordinary differential equations. There are four such equations, (u j ,ũ j , v j ,ṽ j ), for each of the 1,015 vertices in the system; these four nodal equations W=   RH   RH   min   max   LH   LH   lateralorbitofrontal  parsorbitalis  frontalpole  medialorbitofrontal  parstriangularis  parsopercularis  rostralmiddlefrontal  superiorfrontal  caudalmiddlefrontal  precentral  paracentral  rostralanteriorcingulate  caudalanteriorcingulate  posteriorcingulate  isthmuscingulate  postcentral  supramarginal  superiorparietal  inferiorparietal  precuneus  cuneus  pericalcarine  lateraloccipital  lingual  fusiform  parahippocampal  entorhinal  temporalpole  inferiortemporal  middletemporal  bankssts  superiortemporal  transersetemporal are:
where j = 1, . . . , V = 1, 015. Similarly, for the damage model we define a damage variable q j at each node j and assume the same laẇ
where A jk is the network adjacency matrix (A jk = 1 if W jk = 0, and 0 otherwise). This last term expresses the propagation of transneuronal degeneration from a node to its neighbors.
3 Analysis of the continuous model
Homogeneous system
It is instructive to start with an analysis of the homogeneous system obtained by assuming that there is no spatial dependence. This analysis applies to both network and continuous models. In this case, both systems reduce to the dynamical system du dt
where all variables and initial conditions are assumed to be positive and all parameters are strictly positive.
Damage evolution For the homogeneous system above the concentrations remain homogeneous for all time. Damage, in contrast, is node-dependent and expressed by the (nodal) variable q j ∈ [0, 1]. Indeed, in this case, the non-local term associated with transneuronal degeneration, commensurate with the tensor A jk in Eq. (10) , cannot be homogeneous. Nevertheless, the damage dynamics are simple enough to describe. Damage will initially increases linearly in time, homogeneously, from the initial value q j = 0. The increase will then trend exponentially at each node, with node-dependent time scales depending on the local node's degree, and saturate to the value q j = 1 asymptotically in time at each node.
Stationary points
The stationary points and stability of the homogeneous system (11) are instructive; they inform the disease dynamics implied by the local model. The system (11) can exhibit one, two, three, or four stationary points depending on the parameters; these are:
1. Healthy τ P-healthy Aβ: This stationary state is always a solution to (11) and is descriptive of an individual with zero toxic load; no amyloid plaques or neurofibrillary tau tangles. The state is given by:
2. Healthy τ P-toxic Aβ: This state describes a diseased brain wherein some Aβ plaques exist but the tau fibril (NFT) concentration or that of hyperphosphorylated tau is non-existent or negligible. A description of this stationary state in terms of the base problem parameters is:
In terms of u 1 = a 0 /a 1 , from (12) , and u 2 =ã 1 /a 2 it is given by
Since the concentrations must be non-negative: the form ofũ 2 , above, implies that u 1 ≥ u 2 . This results in the condition ofã 1 /a 2 ≤ a 0 /a 1 . In other words either the clearance term of toxic Aβ must be sufficiently small, the conversion term must be sufficiently large, or a ratio of the two, to allow for the existence of a toxic state.
3. Toxic τ P-healthy Aβ: This stationary state is a conceptual dual to the previous state above; granted, toxic τ P does not influence the Aβ population whereas Aβ does induce additional τ P formation. As in (13) we express this state, immediately here, in terms of u 1 = a 0 /a 1 and
Requiring
4. Toxic τ P-toxic Aβ: This stationary state reflects the invasion of a patient's brain by both toxic amyloid beta and toxic tau. As in (12)- (14) we write the state in terms of the previous state variables
Introducing
into (15) gives
Stability
We briefly discuss the stability of the stationary points. In addition we distinguish between the two possible 'disease' phenomena of (11): the case of a disease system characterized by the dynamics of a four-stationary-point model and the case of a disease system characterized by three fixed points.
Eigenvalues of the linearized system The linearization of (11) about any fixed point (u,ũ, v,ṽ) is governed by the Jacobian matrix
The first two eigenvalues of (18) correspond to the Aβ subsystem, e.g. (u,ũ), of (11) . Since the coupling of (11) is a one-way coupling these eigenvalues are given by the corresponding eigenvalues of the uncoupled heterodimer model:
where B(u,ũ, a 1 , a 2 , u 2 ) = a 1 +ã 1 + a 2 (ũ − u) and C(u,ũ, a 1 , a 2 , u 2 ) = a 2 (ã 1ũ − a 1 u) +ã 1 a 1 . The third and fourth eigenvalues of (18) , corresponding to the coupled (v,ṽ) tau system of (11), can be written as
The form of the tau eigenvalues coincides with those for Aβ when b 3 = 0 or whenũ vanishes.
Disease phenomenology
We can interpret the different stationary state in terms of disease dynamics and define, accordingly, different disease states.
The healthy brain. A healthy patient represents an instantiation of the healthy stationary state wherebyũ =ṽ = 0. For the Healthy τ P-healthy Aβ state to exist we must have a 0 ≤ a 1 and A patient in this state has (ũ,ṽ) = (0, 0) and, it can be checked that both (λ Aβ,2 ) < 0 and (λ τ P,2 ) < 0. Moreover, the real parts of remaining eigenvalues are also negative provided
The healthy state (12) is fully stable to perturbations provided (21) , and the corresponding expression for tau, holds. The production of small amounts of toxic Aβ, or of toxic tau, results in a quick return to the healthy homeostatic baseline state. The above implies that the model (6) (7) (8) (9) recognizes the critical role that clearance plays in neurodegenerative diseases. A low value of toxic clearanceã 1 , respectfullyb 1 , with sustained healthy clearance or a low value of healthy clearance a 1 , respectfully b 1 , with sustained toxic clearance is enough to trigger an instability capable of driving the system away from the healthy state.
The susceptible brain From the previous discussion, we conclude that an unfavorable alteration in clearance mechanisms not only renders the healthy state unstable to perturbations but brings into existence the other stationary points characterizing various pathological conditions. Indeed, a well established clinical biomarker for Alzheimer's disease is a drop in soluble amyloid concentration in the cerebrospinal fluid; directly suggesting a decrease in a 1 . Recent evidence also suggest [54] that toxic tau filaments in chronic traumatic encephalopathy patients enclose hydrophobic molecules which may contain blood-born pathogens; a possible result of vascular damage from an impact. Such a finding could imply, for instance, that repeated traumatic injury causes vessel rupture and a subsequent proclivity for this unique form of toxic tau production. The stage is then set to trigger a pathological decline when the critical relation (21), corresponding to tau, is violated due to a balance of increased toxic load and age-induced clearance deficit.
The moment of susceptibility occurs when the inequality of (21) becomes an equality. Mathematically, this parameter configuration is a transcritical bifurcation for the homogeneous system (11) at the coincidence of a combination of the states (12)- (14) . Clinically, this is the point whereby additional stationary states are physically meaningful and pathology development becomes a possibility.
The proteopathic brain The proteopathic brain has suffered a perturbation from the healthy stationary state; due to the instability in the system this patient is progressing towards a diseased state. The potential pathology phenotypes depend on the patient's individual parameter values. In particular, ifã 0 /a 1 ≥ a 1 /a 2 holds then the existence of (13) is physically meaningful and if b 0 /b 1 ≥ b 1 /b 2 holds then the same is true of (14) . It may be the case, depending on the combination of failed clearance subsystems and specific predisposition for toxic loading, that both relations hold simultaneously.
A necessary (clinical) existence criterion for the proteopathic stationary point (15) can be observed directly from the equation forṽ 4 in (17): namely
This implies that the parameter b 3 , defining µ in (16), cannot vanish. Finally since b 3 = 0 and the numerator of of v 4 , in (17) , is always non-negative we see that (15) always exists when u 1 > u 2 and when both v 3 , v 4 ≥ v 1 or when both v 3 , v 4 ≤ v 1 . An important observation is that, though the modeling of the pathology of (15) is tied to that of (13) it is not inextricably tied to (14) ; this is due to the fact that we may always choose b 3 , c.f. (16) , such v 4 is smaller than both v 3 and v 1 . Thus, with a suitably strong Aβ tau-toxification interaction the state (14) is not needed in order to produce tau proteopathy; that is, the model admits a pathology whereby toxic tau is created solely by the presence of toxic Aβ. Therefore, there are two clinically interesting patient proteopathies for our analysis: the case where the patient model consists of all four disease state equilibria, (12)- (15), and the case where the patient model has the three equilibria (12) , (13) and (15).
Primary tauopathy. In this case, all four equilibria exist which requires bothã 1 /a 2 < a 0 /a 1 andb 1 /b 2 < b 0 /b 1 . An example of this dynamics is shown in Figure 2 . We see that the presence of toxic Aβ always implies a higher level of τ P. Indeed, we havẽ
We refer to this case as primary tauopathy as the invasion due to τ P exists independently of Aβ.
The effect of Aβ is to increase the concentration of toxic τ P and, possibly, increase the associated damage. 
Secondary tauopathy. In this regime, toxic τ P can only exist in the presence of Aβ. In secondary tauopathy the evolution of τ P depends on the primary invasion of Aβ. Parameters corresponding to secondary tauopathy can be obtained by
while taking b 3 large enough so thatṽ 4 > 0. 
. Note that trajectories are initialized by taking the initial condition = 0.005 away from an equilibrium point.
Front propagation
We can explore the spatio-temporal behavior of the system by first considering a reduction to one dimension (Ω = R) and subsequently analyzing the spread of toxic protein via the study of traveling waves. From the theory of nonlinear parabolic partial differential equations, we expect pulled fronts that connect one equilibrium state to a different homogeneous state [49] .
First, consider the two uncoupled fronts emanating from the healthy state (u 1 ,ũ 1 , v 1 ,ṽ 1 ) and connecting either to (u 2 ,ũ 2 , v 2 ,ṽ 2 ) or (u 3 ,ũ 3 , v 3 ,ṽ 3 ). To obtain these fronts, we linearize (1) around the healthy state (u 1 ,ũ 1 , v 1 ,ṽ 1 ) and obtain the decoupled system
Starting with initial positive data, the system will develop fronts and the asymptotic selected speed is the minimum possible speed for this linear system [55, 56] . Traveling wave solutions to (24)- (25) are obtained explicitly by first performing a traveling wave reduction (u(x, t) → u(z) with z = x−ct and so on for the other variables) and then looking for linear solutions of the form u = C exp(λz) which leads to a family of possible solution with speeds c = c(λ). The smallest such speed is the selected speed for the asymptotic dynamics. In our case, the front speeds are
where c (ij) β and c (ij) τ denote the speeds of the front from state i to state j (whenever such a front exists) for the Aβ fields (u,ũ) and τ P fields (v,ṽ), respectively. The front speeds for the second transition are 30) x x x x c β (12) c β (12) c β (12) c τ (13) c τ (24) c τ (34) c β (12) c τ Similarly, if both fields are seeded initially, we have
We see that these fronts only exist if a 2 a 0 >ã 1 a 1 and/or b 2 b 0 >b 1 b 1 which are the conditions for the existence of toxic states found in the previous section. Trivially, a front between two states can only develop if such states exist. Second, we consider the possibility of fronts propagating from equilibrium state 2 to state 4. To do so, we linearize the equations around (u 2 ,ũ 2 , v 2 ,ṽ 2 ) and repeat the previous steps to find 
c β (12) c β (12) c β (12) c τ (24) c τ (14) (a) (b) Secondary tauopathy. As a second example, we consider the case where the Aβ front causes the creation of a non-zero toxic τ P state (see Figure 5 ). Initially, a toxic Aβ front propagates to the right in an environment with negligible values of toxic τ P (Figure 5a ). The passage of the front leads to the rapid expansion of toxic τ P (Figure 5b ) which evolves at a speed close to c (Figure 5d ). Third, the front propagating from equilibrium state 3 to state 4 is constrained by the evolution of the u andũ fields. Therefore, we find
Primary tauopathy. As an example of the interactions between the two fronts, we consider a toxic Aβ front on the real axis x propagating to the right interacting with a τ P front propagating to the left (see Figure 4) . They evolve initially with constant speeds c β . The Aβ front is never affected by the presence of toxic τ P.
Network model dynamics
We have established the properties of our system of equations in the homogeneous case and in onedimension. The study has lead to the identification of two fundamental disease propagation modes depending on the parameters: the primary tauopathy where toxic τ P states can exist independently from the Aβ concentration, but are enhanced by its presence; and the secondary tauopathy where the presence of toxic τ P is slaved to the existence of toxic Aβ. We can use this analysis as a guide to the simulation of the full network equation. Equations (6)- (10) were discretized on the reference connectome [53] , c.f. Section 2.2, using CVODE as part of the SUNDIALS nonlinear ODE solver library [57] in addition to KLU [58] as part of the SuiteSparse [59] linear algebra library. Snapshots of the dynamics are shown in subsequent figures, but full movies can be found in the supplementary material.
As a way to systematically test the validity of our computational platform, we have performed two main tests. First, we reproduce the homogeneous states in the full network and second, we reproduce the transition between homogeneous states. Both tests are detailed in Appendix A in addition to a discussion regarding a choice of hypothetical, non-clinical parameters for illustration purposes; c.f. Appendix A.2 for full details on the parameter selection and the resulting numeric values characterizing each pathology state.
Front dynamics on networks
Propagating front solutions for the system of partial differential equations (1) were considered, via linearization around the healthy state and reduction to one spatial dimension, in Section 3.5. Propagating fronts represent fundamental modes of disease pathology dynamics that can also be realized by the network model of (6)- (10) as we now demonstrate. We consider two different network for front propagation. First, a three-dimensional regular cubic lattice with n x = 30 nodes in the x-direction n y = 6 nodes in the y-direction and n z = 3 nodes in the z-direction, spaced equally at unit length. Second, we use the physiological brain connectome domain of Figure 1 , but we choose initial conditions on two sides of the brain to illustrate the front dynamics. In the next section we will consider the same domain but with realistic initial conditions.
Primary tauopathy
The first example is that of primary tauopathy corresponding to the parameters of Table 1 . toxic Aβ. We perturb the initial condition of the right-hand nodes 25 ≤ x ≤ 29 by adding a 5% concentration (ṽ = 0.05) of toxic τ P. As expected, we see the toxic Aβ concentration achieve the theoretical maximum, permitted by the parameters, ofũ = 0.25 while toxic τ P first achieves the maximum associated withṽ = v 3 = 0.25 and, upon mixing with Aβ, achieves the fully toxic state valueṽ = v 4 = 0.45. The color scale of Figure 6 was chosen to accentuate the interaction.
Brain connectome. Simulation of disease front propagation was then carried out using the physiological connectome of Figure 1 . The seeding sites selected for toxic Aβ and toxic τ P are the right supramarginal gyrus and left supramarginal gyrus respectively; these seeding sites provide a direct analogy, when the brain connectome is viewed from the frontal lobe, with Figure 6 . Figure 7 depicts time instances qualitatively reflecting, in one-to-one correspondence, the stages of the synthetic domain computation of Figure 6 . A horizontal slice, at the plane of the supramarginal gyri, of the brain connectome is used to maximally expose the front propagation dynamics. The impact of brain connectome cross-connectivity is evident in the stages depicted in Figure 7 . In particular, when the Aβ and τ P wavefronts first meet they do so in several locations. This is due to the left-right hemispheric connectivity; both direct nodal connectivity and vis-a-vis propagation in the coronal plane.
Secondary tauopathy
Synthetic domain. The parameters for the at-risk secondary tauopathy patient are those of Table 1 with two exceptions; first, as usual for secondary tauopathy, we take b 2 = 0.75 and second we take b 3 = 3.0. We have increased b 3 to facilitate the comparison with Figure 5 . As discussed in Section A.2, see also Figure 3 , secondary tauopathy consists of all stationary states except for the toxic τ P-healthy Aβ state; i.e. 
while the other two secondary tauopathy stationary points, c.f. (12)- (13), coincide with their values for primary tauopathy. The initial value at all nodes are first set to the healthy state. A 5% perturbation in concentration is then added to the toxic Aβ initial value for the nodes 0 ≤ x ≤ 4 and a perturbation of 1 × 10 −9 %, i.e. 1 × 10 −11 , is added to the toxic τ P initial value for the nodes 0 ≤ x ≤ 14. As expected: the initial toxic Aβ wavefront achieves its theoretical maximum of u = 0.25; c.f. Figure 8 vs. Figure 5 . The toxic τ P wave takes on detectable concentration levels at the point when the Aβ wave reaches the halfway mark in the rectangular domain. The toxic τ P state connects, immediately, to the theoretical maximum of the toxic τ P-toxic Aβ stationary state value ofṽ 4 = 7/12 and quickly proceeds to catch up to the Aβ wavefront. We tested the time of appearance and saturation of the toxic τ P wave front as a function of the interaction parameter b 3 . Plots for four values of b 3 are shown in Figure 9 where the y-axis signifies the maximal toxic τ P concentration obtained, over all nodes, with respect to the maximum concentration for that value of b 3 (c.f. (31)). Figure 9 highlights the important, and patient-specific, role that b 3 may play in further efforts to deploy (6)-(9) for the modeling of Alzheimer's disease.
In particular values of b 3 ≈ 1 do lead to the development of tauopathy; however, this development emerges significantly later than for higher values of this interaction parameter. Clinically, such a value of b 3 could correspond to a patient who, at the time of death, presents significant amyloid plaques but negligible, or undetectable, levels of neurofibrillary tau tangles.
Brain connectome. We also simulated secondary tauopathy dynamics on the physiological brain connectome of Figure 1 . A 5% toxic Aβ perturbation from the healthy state was seeded at the site of the left supramarginal gyrus; all nodes of the left hemisphere were then seeded with an additional 1 × 10 −9 % concentration of toxic τ P. Snapshots of the evolution is shown in Figure 10 . As indicated above we have b 3 = 3 for comparison with Figures 8 and 5 . A detail of particular interest is that, even though the entire left hemisphere was seeded uniformly with toxic τ P, the toxic τ P wave follows the same anisotropic infection pathway, from the left supramarginal gyrus, as the toxic Aβ front propagation. This implies that latent development of tauopathy, in this regime, is heavily influenced by Aβ pathology history.
Application to neurodegenerative disease modeling
We have shown in the previous section that the overall phenomenology obtained from the dynamic evolution of the continuous model in one-dimension is recovered within the discrete network setting. We can therefore use the network model and our primary classification to study the interaction of proteins in the brain.
Here, we apply (6)-(9) to a computational case inspired by Alzheimer's disease. In particular we consider seeding sites, for toxic Aβ and toxic τ P, commensurate with [11, 60, 61 , 47] Alzheimer's disease staging. Alzheimer's disease is a complex multiscale phenomena; a uniform parameter regime, throughout all brain regions, is unlikely to accurately reflect a patient's real disease progression. Nevertheless, for this early investigation, we will consider the simple uniform parameters, of the model's primary and secondary tauopathy regimes, as discussed in Section 4. In addition we briefly consider the evolution of the coupled neuronal damage term, given by (10) , and the effect of the coefficients therein. We shall also select the diffusion constants, ρ of (5), to be unity for (6)-(9).
A simplified model of Alzheimer's disease proteopathy
Alzheimer's associated amyloid deposition begins [18, 47, 60, 61] in the temporobasal and frontomedial regions. Tau staging, in Alzheimer's disease, follows the Braak tau pathway [11] and begins in the locus coeruleus and transentorhinal layer [18, 47, 61] . These seeding sites, used throughout this section, are shown in Figure 12 . The temporobasal and frontomedial regions for toxic Aβ seeding are highlighted in red on the left while the locus coeruleus (in the brain stem) and transentorhinal associated regions, for toxic τ P staging, are highlighted red on the right. We compare the simulated primary and secondary tauopathy progression to a qualitative three-stage progression [18] of protein lesions, typical of Alzheimer's disease, as inferred from post-mortem analyses. 
Primary tauopathy
All nodes in the connectome were first set to the healthy, but susceptible, primary tauopathy patient state; c.f. (33) . The temporobasal and frontomedial Aβ seeding sites, consisting of fiftythree nodes, were each seeded with a toxic amyloid concentration of 0.189%; thus the brain-wide toxic Aβ concentration represents a 1% concentration deviation from healthy. Similarly, the locus coeruleus and transentorhinal nodes were seeded with an aggregate perturbation of 1% toxic τ P. Figure (13a) shows the average brain-wide concentration for all four protein populations for the primary tauopathy patient (c.f. Table 1 ) with interaction term b 3 = 1. As we observed previously, in (31) , the value of b 3 directly informs the saturation τ P concentration, of (v,ṽ), for the disease. Figure 13b shows the evolution of the toxic τ P burden for various b 3 . For each value of b 3 the toxic τ P invasion window was computed as the difference in time between the appearance of a global 1% toxic τ P concentration to the simulation time where the maximumṽ was reached. We performed a least squares fit and found that the invasion window, for primary tauopathy, decreases exponentially with an increase in coupling strength (b 3 ) between toxic Aβ and toxic τ P. Figure 13c shows the result. This result suggests that the dynamics of toxic protein evolution is highly sensitive to the coupling between Aβ and τ P: Toxic Aβ accelerates, in a nonlinear fashion, the way toxic τ P emerges across the brain. Acceleration of toxic τ P progression due to the presence of toxic Aβ has also been observed in mouse models of Alzheimer's disease [27] . Consulting longitudinal tau PET studies, in combination with amyloid-beta data from a public database, could provide an estimation of b 3 in the primary tauopathy model.
The toxic load progression of the susceptible primary tauopathy patient is shown in Figure 14 at five equidistant time points throughout the invasion window. To facilitate a comparison with Figure 11 : a sagittal view of the progression, of each toxic agent, is presented; directly below is an opacity-exaggerated view wherein regional opacity is proportional to the agent's regional toxic t = 51 t = 67 t = 83 t = 98 t = 114 Figure 14 : Toxic proteopathy progression dynamics in the primary tauopathy patient. Toxic Aβ (top row) and opacity exaggerated toxic Aβ progression (second row); Toxic τ P (third row) and opacity exaggerated toxic τ P progression (last row). Color scale is identical to Figure 6 load. Comparison with Figure 11 suggests reasonable qualitative agreement; thus warranting further study of physically relevant parameters with a view towards real clinical applications.
Secondary tauopathy
All nodes were set to the healthy, but susceptible, patient state corresponding to the susceptible secondary tauopathy patient parameters (Table 1 with b 2 = 0.75). In addition, for a baseline secondary tauopathy case, we follow Section 4.1 and select the interaction parameter of b 3 = 3.0; the fully invaded secondary tauopathy state values are therefore (31) . Seeding patterns for both Aβ and τ P are identical to the case of primary tauopathy discussed above. Figure 17: Toxic τ P progression dynamics in the secondary tauopathy patient. Toxic τ P (first row) and opacity exaggerated toxic τ P progression (second row). Color scale is identical to the τ P case of Figure 8 Figure (15a) shows the average brain-wide concentration for all four protein populations of the secondary tauopathy patient with baseline interaction term b 3 = 3. As in the case of primary tauopathy we investigate the effect of b 3 on toxic load and invasion window by considering a value range four times smaller to four times larger than the baseline b 3 = 3 case. Toxic load curves are shown in Figure 15b while invasion windows are shown in Figure 15c .
Interestingly, we see distinct differences in comparison with the primary tauopathy case (c.f. Figures 13a-13c ). More specifically, in primary tauopathy it is evident (Figure 13b ) that the disease onset is only slightly affected by varying the interaction parameter b 3 ; for secondary tauopathy, in contrast, b 3 has a profound effect on disease onset latency. Moreover, the invasion window variation with b 3 for secondary tauopathy is more complex than that of primary tauopathy. Figure 13c shows that the invasion window duration initially decreases exponentially with b 3 but then appears to increase logarithmically for b 3 ≥ 3.
Analyzing the invasion window start time and end time separately shows a clear, but separate, exponential decay pattern versus b 3 . Figure 16 shows the least-squares exponential fit to the invasion start and end times.
As in the primary tauopathy case we now consider characteristic toxic load progression for secondary tauopathy. The Aβ progression is identical to that shown in Figure 14 (top two rows) . This is expected as only the τ P portion of the system has been modified with respect to the primary tauopathy regime; see Section A.2. The τ P secondary tauopathy progression is shown, in Figure 17 , at equally spaced simulation times through the invasion window. Qualitatively, the progression of secondary tauopathy also reflects the characteristic post-mortem progression of Figure 11 .
Local and transneuronal damage
In Section 2.1, the continuous equations (1) are augmented with a coarse-grained damage model (2) . This first-pass model aggregates factors, e.g. cellular or vascular etc, contributing to local and transneuronal damage resulting from the presence of the toxic Aβ and τ P protein populations. The coefficients k 1 and k 2 mediate the damaging effect of toxic Aβ and τ P respectively. The rate coefficient k 3 reflects damage, such as the rate of neuronal death following over-excitation, resulting from the combined presence of toxic Aβ and toxic τ P. Finally, k 4 determines the rate of transneuronal damage propagation; thus reflecting aggregate neuronal death as a result of communication disruption to and from regional neighbors. In this illustrative example we consider the parameters
as a baseline from which to begin investigation. These parameters have been chosen to reflect a few clinical observations. First, k 1 is chosen as significantly less than k 2 to reflect the correlation [9, 10, 12, 13] of toxic τ P neurofibrillary tangles with various forms of neuronal damage (e.g. intracellular NFT-induced neuron death, atrophy etc). Second, toxic effects of τ P are increased in the presence of toxic Aβ [12, 26, 28, 29, 30, 31, 32, 33] thus, k 3 is taken larger than k 2 . As a first point of enquiry: we consider our baseline tauopathy patient parameters, laid out in Section A.2, and vary the deafferentation parameter k 4 across three orders of magnitude from the initial value given in (32) . Figures 18a-18b show the results. Note that, in each subfigure, the dashed lines correspond, from left to right, to monotonically decreasing values of k 4 ; the far left dashed curve is k 4 = 1.0, the next curve to the right is k 4 = 1 × 10 −1 , the next is k 4 = 1 × 10 −2 , and so forth, down to the final (rightmost) curve corresponding to k 4 = 1 × 10 −6 . In both figures the baseline deafferentation curve, k 4 = 1 × 10 −3 , is instead solid (and red) for emphasis. Figures 18c-18d show the effect of increasing b 3 ; we have incremented b 3 by two, from baseline, for each case. As expected an overall increase in toxic τ P,ṽ max = 0.679 for primary tauopathy andṽ max = 0.75 for secondary, is observed with the increase in b 3 . However, the limiting behavior of the deafferentation baseline coefficient choice, k 4 = 1 × 10 −3 , remains; which justifies our choice of k 4 in (32). The staging of the damage is presented in two figures: primary tauopathy in Figure 19 and secondary tauopathy in Figure 20 . Each set of figures includes an overhead horizontal plane view in addition to a sagittal view of the right hemisphere. A visualization starting time was selected to coincide with the first visibility of 5% damage, in any nodes, while an ending time was selected such that the damage progression appeared qualitatively equal. Progression times are uniformly spaced within this interval to allow for a direct comparison between the damage distribution within the two regimes. An immediate observation is that a 5% damage detection is latent within the secondary model, starting at t = 95, compared to the primary tauopathy paradigm at t = 80.
It is challenging to discern differences between the fully opaque horizontal views of Figure 19 v.s. Figure 20 ; some discrepancies are apparent in the sagittal views, however. Relative opacity exaggeration is used to gain further insight. At each time the minimum and maximum damage, denoted D min and D max , was computed across all regional nodes of the brain connectome; opacity was then set to linearly increase from: fully transparent at the average 1 2 (D min + D max ); to fully opaque at the maximum value D max . The resulting opacity exaggeration scheme shows, at each time step, the relative distribution of the most damaged regions.
The aforementioned opacity scheme leads to a further observations. First, the distribution of relative significant damage in primary tauopathy ( Figure 19 , second and fourth rows) is clustered more centrally to the toxic τ P seeding site of the transentorhinal cortex. Conversely, the distribution of relative significant damage in secondary tauopathy ( Figure 20 , second and fourth rows) is distributed in the direction of the temporobasal region; a site associated with Aβ seeding. As the disease progressess, t = 103 and t = 114 in Figures 19 and 20 respectively, we see two distinct differences: relative damage is more connected, in the horizontal plane, in addition to more diffuse in the coronal direction, of the sagittal plane, for the case of primary tauopathy; in secondary tauopathy the relative damage in the horizontal plane forms three distinct clusters while severe damage in the sagittal plane is follows the temporobasal and frontomedial directions.
It is increasingly difficult to visually detect qualitative patterns in later stages of significant damage progression; that is, t ≥ 125 for primary tauopathy and t ≥ 133 for secondary. Nevertheless it appears that late stages, t = 148 and t = 170, for primary tauopathy display a more diffuse distribution of significant relative damage away from the transentorhinal region; whereas late secondary tauopathy, t = 151 and t = 170, show more comparative significant damage in the areas associated with Aβ initial seeding. Taken collectively these observations suggest that damage onset and the relative distribution of severe damage may offer distinct points of view for application modelling to both typical Alzheimer's disease along with its neuropathological subtypes [62, 63] .
Conclusion
We have presented a general framework to study protein-interaction in neurodegenerative diseases and introduced a network model of proteopathy that includes interactions between two coupled protein families alongside a model of neuronal damage. The proposed model captures both healthy and toxic protein species. Remarkably, the model admits two distinct disease regimes: primary and secondary tauopathy. In primary tauopathy, toxic tau proteins can exist at a certain concentration level but this level is further boosted by the presence of toxic amyloid beta. In secondary tauopathy, amyloid beta is required for a tauopathy to take place. As we show, much of the model behavior can be extracted from analytical considerations. Additionally, the model can be easily implemented and is computationally tractable to solve, using standard desktop computers, within minutes.
We have employed the proposed model to investigate the dynamics of possible protein interaction and damage evolution in Alzheimer's disease. First, we have shown that proteopathy in this system appears based on the violation of the clearance relations (21) . Mechanisms for amyloid beta and tau clearance in the brain are quite an active area of contemporary research with many open questions [64, 65, 66] . Our work implies that future findings in this area are directly relevant to protein-protein interaction models of prion-like neurodegenerative disease.
Second, we have demonstrated the potentially important interaction between amyloid beta and tau proteins, a recent focal point of many Alzheimer's disease studies [12, 14, 23, 24, 25, 26, 27] . Our model and simulations show that the spreading of toxic proteins in the brain is indeed highly sensitive to the interaction coupling between them. Interestingly, the effect of the coupling are ultimately mediated by the clearance relations (21) ; this implies an, rather unexpected, interdependence between clearance and protein-protein interaction. Specifically, the balance of clearance parameters determines the difference between a primary and secondary tauopathy patient. In turn, the effect of the protein-protein interaction term, is different within these regimes. In primary tauopathy: increase in the interaction (through an increase of the parameter b 3 ) exponentially decreases the invasion window but disease onset is only slightly affected. In secondary tauopathy: increasing b 3 demonstrates more complex behavior, combining exponential decay followed by logarithmic growth, on the invasion window and has a dramatic affect on disease onset. Both cases show that, indeed, amyloid-beta and tau proteins conspire with each other during disease development.
Alzheimer's disease is a complex and multi-scale disease. The need for mathematical models, presenting observed disease characteristics, that are computationally tractable is pressing. Our findings suggest that further enquiry into both protein interaction and clearance processes is an important path forward in elucidating key mechanisms in the progression of these diseases. 
A Numerical verification
In this appendix we test our computational platform by recovering the basic homogeneous dynamics of the full network model. To do this we use two hypothetical sets of illustrative, non-clinical parameters; one set of parameters for each regime. In Section A.1 we illustrate the four possible patient states (stationary points) of Section 3.2. In Section A.2 the primary and secondary tauopathy, c.f. Section 3.3, patient state transitions are simulated and model patient dynamics are discussed in more detail. Front propagation in the brain connectome network is confirmed using synthetic left-right hemisphere initial seedings in Section 4.1.
A.1 Patient states of the network system
We now briefly illustrate the four stationary states of the homogeneous system discussed in Section 3.1. To demonstrate that each of the predicted stationary points is indeed a stationary point of the homogeneous network system, c.f. Section 3.1, we select illustrative parameters that satisfy the requisite characterizing inequalities. Every node in the brain network is then seeded with the initial value corresponding to the selected fixed point. We expect, and demonstrate, that the system remains stable at that fixed point.
We will confirm the stationary points by selecting the effective diffusion constant, ρ of (5), as unity and solving (6)-(10) for t ∈ [0, 10] using one thousand time-steps. For the healthy Aβ-healthy τ P state, c.f. (12), we select a 0 = 0.75 and b 0 = 0.5; all other parameters are set to unity. All nodes were seeded with the corresponding initial value Figure 21a shows the plot of global mean tracer concentration with time and confirms that the healthy Aβ-healthy τ P state is stationary under the given conditions. For the healthy τ P-toxic Aβ (12)- (15) fixed point, c.f. (13), we begin with the previous parameters and reduce the toxic Aβ clearance by 40%. We therefore haveã 1 = 0.6 and keep the previous parameters fixed. We then have
The stationary behavior is again demonstrated; c.f. Figure 21b . For the third stationary state, given by (14), we begin once more with the parameters of the healthy Aβ-healthy τ P state and reduce the toxic tau clearance parameter by 60%. We then haveb 1 = 0.4 and keep all other parameters as in the healthy Aβ-healthy τ P state. All nodes are then set to the corresponding initial value
Once more, Figure 21c , we see the stationary characteristic we expect. For the final stationary point, c.f. (17), we use the reduced toxic clearance parameters from the second and third stationary points above,ã 1 = 0.6 andb 1 = 0.4, in addition to the original production values, a 0 = 0.75 and b 0 = 0.5, of Aβ and τ P respectively. All other parameters not explicitly mentioned are again taken to be unity. Given these choices we can directly compute µ and v 4 , via (16)- (17), as Using the above, along with the expressions for v 1 , v 3 , u 1 , u 2 andũ 2 from (12)- (14) , the value ofṽ 4 is given directly from the fourth entry of (17) as The final plot, for the fourth stationary point, is shown in Figure 21d . Coronal and sagittal plane views of the stationary point verification computation at t = 10 are shown in Figure 22 .
A.2 Patient pathology transitions of the network system
We briefly illustrate the homogeneous state dynamics of the network system; verifying the theoretical view of Section 3.3 on the complex brain network geometry of Figure 1 .
A.2.1 Primary tauopathy
We consider a hypothetical susceptible model patient characterized by the parameters chosen in Appendix A.1. All four of the stationary points discussed in Section 3.2 coexist with this choice of parameters; hence, these parameters fall into the regime of primary tauopathy. In this section we Figure 22 , of (6)-(10) discretized on the brain network geometry of Figure 1 . The selected illustrative primary tauopathy parameters are collected in Table 1 for posterity. The eigenvalues, (19) and (20) , at the healthy Aβ-healthy τ P stationary point (u,ũ, v,ṽ) = (0.75, 0, 0.5, 0) can be calculated. We see that λ Aβ,1 , λ τ P,1 < 0, i.e. stable to healthy Aβ and τ P perturbations, while λ Aβ,2 , λ τ P,2 > 0 so that the otherwise healthy patient brain is susceptible to perturbations in both toxic Aβ and toxic τ P. Utilizing the given parameters to evaluate the stability properties at the second stationary point, (u,ũ, v,ṽ) = (0.6, 0.25, 0.5, 0) c.f. (13), we have λ Aβ,1 , λ Aβ,2 , λ τ P,1 < 0 and λ τ P,2 > 0; at this state the patient is susceptible only to a perturbation in toxic tau. Likewise at the third stationary point, (u,ũ, v,ṽ) = (0.75, 0, 0.4, 0.25) c.f. (14), we have λ Aβ,1 , λ τ P,1 , λ τ P,2 < 0 and λ Aβ,2 > 0 so that the patient in this state is only susceptible to an addition of toxic Aβ. Finally the fixed point (15) is fully stable, i.e. all eigenvalues are negative, and no further disease transition is possible from this state.
Verifications of the primary tauopathy homogeneous state transitions, first depicted in Figure 2 , for the full connectome simulation are shown in Figure 23 . For instance the healthy state, (u 1 ,ũ 1 , v 1 ,ṽ 1 ), perturbation with respect to both toxic Aβ and toxic τ P results in the fully toxic state, (u 4 ,ũ 4 , v 4 ,ṽ 4 ); this is shown in Figure 23c and appears in Figure 2 as the blue (diagonal) path.
A.2.2 Secondary tauopathy
The secondary tauopathy disease model arises when v 1 < v 3 , so that the stationary point (14) is in an unphysical state, while (12), (13) and (15) remain well defined. One way that this can be Figure 24 : Hτ P-HAβ,ṽ stable achieved is for b 3 , the coefficient mediating the effect of toxic Aβ protein on inducing healthy tau toxification, to be such that both v 4 < v 1 and v 4 < v 3 ; a decrease in b 2 can also accomplish this goal, c.f. (15) . We see that the first and second stationary points are identical to the case of primary tauopathy and the fourth is perturbed in the (v,ṽ) components. Strictly speaking, the healthy patient in this regime is susceptible only to toxic Aβ infection; that is λ Aβ,1 , λ τ P,1 , λ τ P,2 < 0 and λ Aβ,2 > 0 at (u 1 ,ũ 1 , v 1 ,ṽ 1 ). Verification of the healthy state robustness to perturbations in toxic tau,ṽ, is shown in Figure 24 .
At the healthy state λ Aβ,2 > 0 holds. Thus, the susceptible, but otherwise healthy, secondary tauopathy patient is at risk of directly developing Aβ proteopathy. This is verified by perturbing the healthy state by a small concentration inũ; the pursuant transition from the Healthy τ PHealthy Aβ state to the Healthy τ P-Toxic Aβ state is pictured in Figure 25b . Having arrived at (u 2 ,ũ 2 , v 2 ,ṽ 2 ) the patient is now susceptible to tauopathy as λ τ P,2 > 0 there; perturbingṽ then develops to the Toxic τ P-Toxic Aβ state as shown in Figure 25c .
In fact, as postulated in Section 3.3 c.f. Figure 3 , the fully diseased state (u 4 ,ũ 4 , v 4 ,ṽ 4 ) is reachable from the healthy state provided that toxic Aβ is present alongside some toxic tau perturbation. This can be seen directly from λ τ P,2 in (20) . Consider the Taylor expansion of (20) , evaluated with b 2 = 0.75 and all other parameters as in Table 1 , aboutṽ = 0. We first set θ =ũ + 0.6 and we let 0 ≤ 1 be denote a small perturbation inṽ. It is evident that the effect on λ τ P,2 due to a perturbation in toxic tau depends here on both toxic amyloid,ũ, and healthy tau, v, concentration levels. Then, using thatũ ≥ 0, and v ≥ 0, we approximate (20) , to order 2 , aroundṽ = 0 by λ τ P,2 ( ) ≈ θv 1 − θ θv + 0.6 − 0.4.
If we presume, for instance, that the susceptible secondary tauopathy patient has healthy levels of tau protein, i.e. that v = v 1 = 0.5, we can directly visualize the effect of toxic Aβ on λ τ P,2 . Figure  26 shows the approximate value of λ τ P,2 (y-axis, c.f. (34)) versus the toxic Aβ value θ(ũ) =ũ + 0.75 (x-axis) for three given perturbations . Evidently, as decreases the effect ofũ on increasing λ τ P,2 is not diminished. Thus an initial toxic τ P seed will develop into a full blown infection providedũ is present, or quickly develops, in sufficient quantity to evolve λ τ P,2 above zero. This is precisely the behavior predicted in Section 3.3 ( Figure 3 ). In accordance we see, c.f. Figure 25a , that perturbing bothũ andṽ simultaneously from the initial healthy state induces direct evolution to fully diseased state.
